Dr. Wang Receives Honor Award from the American Society of Retina Specialists
In recognition of his time and contributions to the scientific programs of the organization’s annual meetings, Texas Retina’s Robert C. Wang, MD, has earned the Honor Award from the American Society of
read more
Dr. Abbey Shares Clinical Insights on Management of Wet AMD
Texas Retina’s Dr. Ashkan Abbey recently discussed neovascular (wet) age-related macular degeneration (AMD) management on Vumedi, a video education and peer-to-peer learning platform for doctors and medical professionals. Dr. Abbey’s video presentation
read more
Dr. Choi Discusses Macular Hole Diagnosis, Surgery and Management
Texas Retina’s Rene Y. Choi, MD, PhD, was recently invited to present at the Excellence in Eye Care Symposium, the 2026 annual meeting of Cornea Associates of Texas. Dr. Choi’s talk was
read more
Dr. Abbey Discusses the New Era of Geographic Atrophy Management
Texas Retina’s Ashkan M. Abbey, MD, recently participated in a three-part special report video series by Ophthalmology Times that examined the evolving treatment landscape for geographic atrophy (GA). What is Geographic Atrophy?
read more
Getting to Know Ocular Oncologist Timothy S. Fuller, MD
May is Ocular Melanoma Awareness Month. Ocular (uveal) melanoma is a rare but dangerous disease, and only a small number of doctors in the United States treat it. At Texas Retina Associates, we have
read more
Our Offices Will Close for Memorial Day
All Texas Retina offices will be closed on Monday, May 25, in observance of Memorial Day. We remember and honor all those who gave their lives in service to our country.
read more
Dr. Abbey Presented on Retinal Sustained Drug Delivery Research at Retina World Congress
At the recently held Retina World Congress 2026 meeting, Texas Retina’s Dallas Director of Clinical Research Ashkan M. Abbey, MD, presented on the evolving clinical trial landscape for sustained drug delivery in retinal disease. Dr.
read more
May is Ocular Melanoma Awareness Month
Ocular (uveal) melanoma is a rare but dangerous disease. It involves the iris, ciliary body, and/or choroid, which are collectively referred to as the uvea, and the tumors develop in the pigmented
read more
Dr. Abbey Discusses Retinal Vein Occlusion as a Marker of Systemic Risk
Texas Retina’s Ashkan Abbey, MD, recently appeared on the ReachMD podcast to discuss “Retinal Vein Occlusion as a Marker of Systemic Risk.” This was the third episode he contributed to their “Eye
read more
